Skip to main content

Bausch & Lomb Corp

BLCO
Exchange
NYSE
Industry
Ophthalmic Goods
SEC CIK
0001860742

In the last 90 days, Bausch & Lomb Corp insiders filed 0 open-market purchases and 2 sales; 99 institutions reported holding it in 13F filings for Q2 2026, worth $638.7M in total; 3 superinvestors hold it, including Icahn Capital and Oaktree Capital.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $1.19M in total
2
13F holdersQ2 2026, +4 vs. previous quarter
99
13F valueReported value at the end of Q2 2026
$638.7M
Superinvestors holdingAt the end of Q2 2026
3

Price chart

Superinvestors holding BLCO, Q2 2026

3 superinvestors report holding Bausch & Lomb Corp on Form 13F. Percentages are the stock's share of each portfolio.

Go to the superinvestors tab

Icahn Capital

Carl Icahn

0.7%

Bausch & Lomb Corp's share of the portfolio

Shares
3,500,000
Value
$58.0M

Oaktree Capital

Howard Marks

1.1%

Bausch & Lomb Corp's share of the portfolio

Shares
3,441,042
Value
$57.0M
Other superinvestors holding BLCO (part 1)
SuperinvestorWeightValue
Third Point<0.1%$1.41M

Latest insider trades

Open-market purchases and sales by Bausch & Lomb Corp insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 12, 2026 (view filing)7:06 PM ETAug 102 daysMunsch FrederickSVP, Controller and CAOSSaleCommon Shares, No Par Value−52.9K$16.78−$887.7K−53.6%45.8K after
Aug 10, 2026 (view filing)8:57 PM ETAug 6-74 daysVon Eschenbach Andrew C.DirectorSSaleCommon Shares, No Par Value−18.6K$16.53−$306.7K−22.6%63.7K after2 lots
Mar 10, 2026 (view filing)Mar 64 daysBailey A Robert DEVP & Chief Legal OfficerPPurchaseCommon Shares, No Par Value+14.6K$17.15+$250.4K+6.7%231.9K after
Mar 10, 2026 (view filing)Mar 64 daysEldessouky SamEVP and CFOPPurchaseCommon Shares, No Par Value+4.00K$17.13+$68.5K+1.0%403.1K after
Mar 10, 2026 (view filing)Mar 64 daysSaunders Brent LCEO and Chairman of the BoardPPurchaseCommon Shares, No Par Value+14.7K$17.14+$252.0K+1.5%966.6K after
Mar 4, 2026 (view filing)Mar 31 dayRoss Thomas W. Sr.DirectorPPurchaseCommon Shares, No Par Value+4.50K$17.68+$79.6K+7.5%64.9K after
Mar 3, 2026 (view filing)Mar 21 dayAlfonso EduardoDirectorPPurchaseCommon Shares, No Par Value+4.30K$17.90+$77.0K+81.8%9.55K after
Mar 3, 2026 (view filing)Feb 274 daysVon Eschenbach Andrew C.DirectorPPurchaseCommon Shares, No Par Value+4.36K$18.31+$79.9K+7.0%66.5K after
Feb 24, 2026 (view filing)Feb 231 dayCollis Steven HDirectorPPurchaseCommon Shares, No Par Value+15.0K$17.81+$267.1K+285.4%20.3K after
Feb 24, 2026 (view filing)Feb 204 daysRobertson Russel CDirectorPPurchaseCommon Shares, No Par Value+4.40K$17.90+$78.8K+6.5%72.4K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Bausch & Lomb Corp at the end of Q2 2026; share changes are against Q1 2026.

See all 99 holders
Institutions holding BLCO in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Icahn Carl CSuperinvestorIcahn Capital3,500,000$58.0M0.70%00.0%Unchanged
Oaktree Capital Management LPSuperinvestorOaktree Capital3,441,042$57.0M1.07%+58,303+1.7%Added
Deutsche Bank AG3,423,046$56.7M0.02%−105,395−3.0%Reduced
D. E. Shaw & Co., Inc.3,323,021$55.0M0.03%+171,854+5.5%Added
Davidson Kempner Capital Management LP3,158,972$52.3M0.84%+959,800+43.6%Added
Goldentree Asset Management LP2,660,508$44.0M2.56%00.0%Unchanged
Price T Rowe Associates Inc2,161,232$35.8M0.00%+936,629+76.5%Added
Caspian Capital LP1,999,043$33.1M18.80%00.0%Unchanged
Glenview Capital Management, LLC1,918,148$31.8M0.63%+7,652+0.4%Added
Arrowstreet Capital, Limited Partnership1,364,980$22.6M0.01%+382,918+39.0%Added